The antiphospholipid syndrome

Best Practice and Research: Clinical Rheumatology

Volumn 22, Issue 5, 2008, Pages 831-845

  Pasquali, Jean Louis ^a   Poindron, Vincent ^a   Korganow, Anne Sophie ^a   Martin, Thierry ^a  

^a HÔPITAL CIVIL   (France)

Author keywords

anticardiolipin antibodies; antiphospholipid syndrome; lupus anticoagulant

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; CHOREA; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DISEASE CLASSIFICATION; ECLAMPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS DEATH; HEART INFARCTION; HUMAN; INTRACARDIAC THROMBOSIS; KIDNEY DISEASE; LIVEDO RETICULARIS; MIGRAINE; MORBIDITY; OSTEOPENIA; PATHOPHYSIOLOGY; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; REVIEW; SPINAL CORD DISEASE; SPONTANEOUS ABORTION; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VALVULAR HEART DISEASE; VEIN THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; PREGNANCY; YOUNG ADULT;

EID: 57049109275     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2008.08.008     Document Type: Review

References (85)

1. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis and Rheumatism 42 (1999) 1309-1311
2. Lockshin M.D., Sammaritano L.R., and Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis and Rheumatism 43 (2000) 440-443
3. Sanna G., Bertolaccini M.L., Cuadrado M.J., et al. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 42 (2003) 200-213
4. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis and Rheumatism 46 (2002) 1019-1027
5. Tektonidou M.G., and Moutsopoulos H.M. Osteoarticular manifestations of antiphospholipid syndrome. Rheumatic Diseases Clinics of North America 32 (2006) 523-535
6. Espinosa G., Santos E., Cervera R., et al. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine 82 (2003) 106-118
7. Deschiens M.A., Conard J., Horellou M.H., et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 27 (1996) 1724-1730
8. Palmowski-Wolfe A.M., Denninger E., Geisel J., et al. Antiphospholipid antibodies in ocular arterial and venous occlusive disease. Ophthalmologica 221 (2007) 41-46
9. Hirohata Y., Murata A., Abe S., and Otsuki M. Portal vein thrombosis associated with antiphospholipid syndrome. Journal of Gastroenterology 36 (2001) 574-578
10. Opatrny L., David M., Kahn S.R., et al. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. The Journal of Rheumatology 33 (2006) 2214-2221
11. Dreyfus M., Hedelin G., Kutnahorsky R., et al. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstetrics and Gynecology 97 (2001) 29-34
12. Lee R.M., Brown M.A., Branch D.W., et al. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Obstetrics and Gynecology 102 (2003) 294-300
13. Branch D.W., Porter T.F., Rittenhouse L., et al. Antiphospholipid antibodies in women at risk for preeclampsia. American Journal of Obstetrics and Gynecology 184 (2001) 825-832
14. Galli M., Luciani D., Bertolini G., and Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101 (2003) 1827-1832
15. Wong R.C., and Australasian aCL Working Party. Consensus guidelines for anticardiolipin antibody testing. Thrombosis Research 114 (2004) 559-571
16. Tincani A., Allegri F., Balestrieri G., et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thrombosis Research 114 (2004) 553-558
17. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis 4 (2006) 295-306
18. Cooper R., Cutler J., Desvigne-Nickens P., et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 102 (2000) 3137-3147
19. Male C., Foulon D., Hoogendoorn H., et al. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 106 (2005) 4152-4158
20. Erkan D., Derksen W.J., Kaplan V., et al. Real world experience with antiphospholipid antibody tests: how stable are results over time?. Annals of the Rheumatic Diseases 64 (2005) 1321-1325
21. Forastiero R., Martinuzzo M., Pombo G., et al. A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. Journal of Thrombosis and Haemostasis 3 (2005) 1231-1238
22. Zoghlami-Rintelen C., Vormittag R., Sailer T., et al. The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant. Journal of Thrombosis and Haemostasis 3 (2005) 1160-1165
23. Lopez L.R., Dier K.J., Lopez D., et al. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. American Journal of Clinical Pathology 121 (2004) 142-149
24. Von Scheven E., Glidden D.V., and Elder M.E. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. Arthritis and Rheumatism 47 (2002) 414-420
25. Faden D., Tincani A., Tanzi P., et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. European Journal of Obstetrics, Gynecology, and Reproductive Biology 73 (1997) 37-42
26. Forastiero R.R., Martinuzzo M.E., Cerrato G.S., et al. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thrombosis and Haemostasis 78 (1997) 1008-1014
27. Lee R.M., Emlen W., Scott J.R., et al. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. American Journal of Obstetrics and Gynecology 181 (1999) 642-648
28. Neville C., Rauch J., Kassis J., et al. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thrombosis and Haemostasis 90 (2003) 108-115
29. Lee E.Y., Lee C.K., Lee T.H., et al. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis?. Thrombosis Research 111 (2003) 29-32
30. Pengo V., Biasiolo A., Pegoraro C., et al. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thrombosis and Haemostasis 93 (2005) 1147-1152
31. Ruffatti A., Tonello M., Del Ross T., et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thrombosis and Haemostasis 96 (2006) 337-341
32. Kaul M., Erkan D., Sammaritano L., and Lockshin M.D. Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Annals of the Rheumatic Diseases 66 (2007) 927-930
33. Brandt J.T., Barna L.K., and Triplett D.A. Laboratory identification of lupus anticoagulants: results of the second international workshop for identification of lupus anticoagulants. On behalf of the subcommittee on lupus anticoagulants/antiphospholipid antibodies of the ISTH. Thrombosis and Haemostasis 74 (1995) 1597-1603
34. Lockwood C.J., Romero R., Feinberg R.F., et al. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. American Journal of Obstetrics and Gynecology 161 (1989) 369-373
35. de Laat B., Derksen R.H., van Lummel M., et al. Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. Blood 107 (2006) 1916-1924
36. Pasquali J.L., Poindron V., Korganow A.S., and Martin T. Pathogenesis of the antiphospholipid syndrome. La Presse médicale 36 (2007) 667-673
37. Lieby P., Soley A., Levallois H., et al. The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity. Blood 97 (2001) 3820-3828
38. Petri M. Epidemiology of the antiphospholipid antibody syndrome. Journal of Autoimmunity 15 (2000) 145-151
39. Vila P., Hernández M.C., López-Fernández M.F., and Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thrombosis and Haemostasis 72 (1994) 209-213
40. Crowther M.A., and Wisloff F. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis. Thrombosis Research 115 (2005) 3-8
41. Harris E.N., and Pierangeli S.S. Revisiting the anticardiolipin test and its standardization. Lupus 11 (2002) 269-275
42. Panzer S., Gschwandtner M.E., Hütter D., et al. Specificities of platelet autoantibodies in patients with lupus anticoagulants in primary antiphospholipid syndrome. Annals of Hematology 74 (1997) 239-242
43. Schallmoser K., Rosin C., Vormittag R., et al. Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic disease. Lupus 15 (2006) 507-514
44. Diz-Küçükkaya R., Hacihanefioǧlu A., Yenerel M., et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 98 (2001) 1760-1764
45. Rottem M., Krause I., Fraser A., et al. Autoimmune hemolytic anaemia in the antiphospholipid syndrome. Lupus 15 (2006) 473-477
46. Arvieux J., Schweizer B., Roussel B., and Colomb M.G. Autoimmune haemolytic anaemia due to anti-phospholipid antibodies. Vox Sanguinis 61 (1991) 190-195
47. Brey R.L., Chapman J., Levine S.R., et al. Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus 12 (2003) 508-513
48. Hanly J.G., Hong C., Smith S., and Fisk J.D. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis and Rheumatism 42 (1999) 728-734
49. Menon S., Jameson-Shortall E., Newman S.P., et al. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis and Rheumatism 42 (1999) 735-741
50. Tektonidou M.G., Varsou N., Kotoulas G., et al. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Archives of Internal Medicine 166 (2006) 2278-2284
51. Chapman J., Abu-Katash M., Inzelberg R., et al. Prevalence and clinical features of dementia associated with the antiphospholipide syndrome and circulating anticoagulants. Journal of the Neurological Sciences 203-204 (2002) 81-84
52. Asherson R.A., Khamashta M.A., Gil A., et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. The American Journal of Medicine 86 (1989) 391-399
53. Westerman E.M., Miles J.M., Backonja M., and Sundstrom W.R. Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event. Arthritis and Rheumatism 35 (1992) 1038-1041
54. Cervera R., Asherson R.A., Font J., et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine 76 (1997) 203-212
55. Tietjen G.E., Day M., Norris L., et al. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology 50 (1998) 1433-1440
56. Verrot D., San-Marco M., Dravet C., et al. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. The American Journal of Medicine 103 (1997) 33-37
57. Hojnik M., George J., Ziporen L., and Schoerfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93 (1996) 1579-1587
58. Margarita A., Batuca J., Scenna G., et al. Subclinical atherosclerosis in primary antiphospholipid syndrome. Annals of the New York Academy of Sciences 1108 (2007) 475-480
59. Francès C., Niang S., Laffitte E., et al. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis and Rheumatism 52 (2005) 1785-1793
60. Uthman I., and Khamashta M. Antiphospholipid syndrome and the kidneys. Seminars in Arthritis and Rheumatism 35 (2006) 360-367
61. Tektonidou M.G., Sotsiou F., Nakopoulou L., et al. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis and Rheumatism 50 (2004) 2569-2579
62. Asherson R.A. The catastrophic antiphospholipid (Asherson's) syndrome. Autoimmunity Reviews 6 (2006) 64-67
63. Asherson R.A., Espinosa G., Menahem S., et al. Relapsing Catastrophic Antiphospholipid Syndrome: Report of Three Cases. Seminars in Arthritis and Rheumatism 37 (2008) 366-372
64. Miesbach W., Asherson R.A., Cervera R., et al. The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmunity Reviews 6 (2006) 94-97
65. Zhang J., and McCrae K.R. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 105 (2005) 1964-1969
66. Fischetti F., Durigutto P., Pellis V., et al. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood 106 (2005) 2340-2346
67. Lutters B.C., Derksen R.H., Tekelenburg W.L., et al. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. The Journal of Biological Chemistry 278 (2003) 33831-33838
68. Cesarman-Maus G., Ríos-Luna N.P., Deora A.B., et al. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood 107 (2006) 4375-4382
69. Rand J.H., Wu X.X., Quinn A.S., et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. The American Journal of Pathology 163 (2003) 1193-1200
70. Salmon J.E., and Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. Journal of Reproductive Immunology 77 (2008) 51-56
71. Lieby P., Poindron V., Roussi S., et al. Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack. Blood 15 104 (2004) 1711-1715
72. Crowther M.A., Ginsberg J.S., Julian J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. The New England Journal of Medicine 349 (2003) 1133-1138
73. Finazzi G., Marchioli R., Brancaccio V., et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis 3 (2005) 848-853
74. Schulman S., Svenungsson E., and Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of anticoagulation study group. The American Journal of Medicine 104 (1998) 332-338
75. Finazzi G., Brancaccio V., Moia M., et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. The American Journal of Medicine 100 (1996) 530-536
76. Khamashta M.A., Cuadrado M.J., Mujic F., et al. The management of thrombosis in the antiphospholipid-antibody syndrome. The New England Journal of Medicine 332 (1995) 993-997
77. Levine S.R., Brey R.L., Tilley B.C., et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA : The Journal of the American Medical Association 291 (2004) 576-584
78. Mohr J.P., Thompson J.L., Lazar R.M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. The New England Journal of Medicine 345 (2001) 1444-1451
79. Empson M., Lassere M., Craig J., and Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews (Online) (2005 Apr 18) CD002859
80. Farquharson R.G., Quenby S., and Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics and Gynecology 100 (2002) 408-413
81. Bates S.M., Greer I.A., Hirsh J., and Ginsberg J.S. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 627S-644S
82. Tincani A., Branch W., Levy R.A., et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12 (2003) 524-529
83. Deruelle P., and Coulon C. The use of low-molecular-weight heparins in pregnancy-how safe are they?. Current Opinion in Obstetrics & Gynecology 19 (2007) 573-577
84. Erkan D., Merrill J.T., Yazici Y., et al. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis and Rheumatism 44 (2001) 1466-1467
85. Alarcón-Segovia D., Boffa M.C., Branch W., et al. Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus 12 (2003) 499-503